Equities research analysts at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a report released on Wednesday. The brokerage set a “hold” rating on the ...

After hours: January 31 at 4:08:13 PM EST Loading Chart for CTSO ...

Research reports are not currently available for CTSO.

Cytosorbents had a negative net margin of 49.47% and a negative return on equity of 118.54%. The business had revenue of $9.39 million during the quarter, compared to analysts’ expectations of ...

13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood ...

Analysts' ratings for CytoSorbents CTSO over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below offers a condensed view of their recent ratings, showcasing ...

13, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

CytoSorbents (CTSO) (ISIN: US23283X2062)股票专题，提供今日CytoSorbents(CTSO) (ISIN: US23283X2062)股票最新股价查询，实时市场行情，走势图表，及CytoSorbents Corp.(CTSO) (ISIN: US23283X2062)股票的专业技术分析，投资者论坛，历史交易数据，最新消息和未来价格预测。

PRINCETON, N.J., Jan. 06, 2025 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...